Germany - Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8\/130c para. 1 SGB
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 30 June 2026
- Opportunity publication date
- 17 July 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8\/130c para. 1 SGB V for medicinal products with the active ingredient dupilumab (D11AH05) within the period from 01.09.2024 to 31.08.2026 with the possibility of concluding an agreement at any time (open house model). In the open house procedure, medicinal products according to the BfArM list pursuant to Section 35 para. 5a SGB V (pediatric medicinal products) are excluded.
- Opportunity closing date
- 30 June 2026
- Value of contract
- to be confirmed
About the buyer
- Address
- AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.